BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38282144)

  • 1. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
    Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
    J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
    Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
    J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
    Yao H; Li J; Zhou D; Pan X; Chu Y; Yin J
    Int J Clin Oncol; 2024 Mar; 29(3):333-344. PubMed ID: 38172354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
    Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
    Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
    Li H; Tang X; Sun Z; Qu Z; Zou X
    Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
    Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
    BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broussoflavonol B from
    Jeong JH; Ryu JH
    Molecules; 2020 May; 25(10):. PubMed ID: 32429421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.
    Wolter P; Hanselmann S; Pattschull G; Schruf E; Gaubatz S
    Oncotarget; 2017 Feb; 8(7):11160-11172. PubMed ID: 28061449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of FOXM1 suppresses cell growth and metastasis in human laryngeal cancer via the AKT signaling pathway.
    Yan J; Hou J; Yan Y; Ren XY; Luo HN; Wang ZG; Zheng GX
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6786-6793. PubMed ID: 32633370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxM1 Regulates Proliferation and Apoptosis of Human Neuroblastoma Cell through PI3K/AKT Pathway.
    Liao J; Jiang L; Wang C; Zhao D; He W; Zhou K; Liang Y
    Fetal Pediatr Pathol; 2022 Jun; 41(3):355-370. PubMed ID: 32901528
    [No Abstract]   [Full Text] [Related]  

  • 16. Apoptotic effect of lambertianic acid through AMPK/FOXM1 signaling in MDA-MB231 breast cancer cells.
    Lee JH; Lee HJ; Sim DY; Jung JH; Kim KR; Kim SH
    Phytother Res; 2018 Sep; 32(9):1755-1763. PubMed ID: 29722086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
    Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
    Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1.
    Cınar V; Hamurcu Z; Guler A; Nurdinov N; Ozpolat B
    Breast Cancer; 2022 Nov; 29(6):1106-1120. PubMed ID: 36006564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
    Zhang X; Wang M; Zhang Y; Yang J; Duan W
    Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells.
    Yan D; Yan X; Dai X; Chen L; Sun L; Li T; He F; Lian J; Cai W
    Oncol Rep; 2019 Aug; 42(2):785-796. PubMed ID: 31233189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.